Antiepileptic drugs and their impact on balance
暂无分享,去创建一个
[1] R. Fisher,et al. Measuring the effects of antiepileptic medications on balance in older people , 2006, Epilepsy Research.
[2] B. Uthman,et al. New onset geriatric epilepsy , 2005, Neurology.
[3] A. Sólyom,et al. Dose‐dependent Safety and Efficacy of Zonisamide: A Randomized, Double‐blind, Placebo‐controlled Study in Patients with Refractory Partial Seizures , 2005, Epilepsia.
[4] A. Marson,et al. Zonisamide add-on for drug-resistant partial epilepsy. , 2005, The Cochrane database of systematic reviews.
[5] W. Hwang,et al. Acute Phenytoin Intoxication: Causes, Symptoms, Misdiagnoses, and Outcomes , 2004, The Kaohsiung journal of medical sciences.
[6] M. Brodie. Zonisamide clinical trials: European experience , 2004, Seizure.
[7] B. Parsons,et al. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. , 2004, The American journal of geriatric pharmacotherapy.
[8] W. Löscher,et al. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions , 2004, Nature Medicine.
[9] J. Salas-Puig,et al. Seguridad del levetiracetam como tratamiento adyuvante en la epilepsia: el estudio SKATE en España , 2004 .
[10] P. J. Bowman,et al. Antiepileptic drug use increases rates of bone loss in older women , 2004, Neurology.
[11] J. Sackellares,et al. Randomized, Controlled Clinical Trial of Zonisamide as Adjunctive Treatment for Refractory Partial Seizures , 2004, Epilepsia.
[12] R. Ramsay,et al. Special considerations in treating the elderly patient with epilepsy , 2004, Neurology.
[13] R. Mattson,et al. Fractures, epilepsy, and antiepileptic drugs , 2004, Epilepsy & Behavior.
[14] F. Matsuo,et al. Long-term tolerability of lamotrigine: data from a 6-year continuation study , 2004, Epilepsy & Behavior.
[15] G. Baker,et al. Systematic screening allows reduction of adverse antiepileptic drug effects , 2004, Neurology.
[16] I. Leppik,et al. Epilepsy in the Elderly , 2002, Seminars in neurology.
[17] S. Schmidt,et al. Signs and symptoms of carbamazepine overdose , 1995, Journal of Neurology.
[18] M. Morrell,et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial , 2003, Epilepsy & Behavior.
[19] J. Cramer,et al. Tolerability of levetiracetam in elderly patients with CNS disorders , 2003, Epilepsy Research.
[20] A. Beydoun,et al. Sustained Efficacy and Long‐term Safety of Oxcarbazepine: One‐year Open‐label Extension of a Study in Refractory Partial Epilepsy , 2003, Epilepsia.
[21] L. Eberly,et al. Antiepileptic drug use in nursing home admissions , 2003, Annals of neurology.
[22] A. Beydoun,et al. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy , 2003, Epilepsy & Behavior.
[23] D. H. Kennedy,et al. The use of gabapentin for the treatment of postherpetic neuralgia. , 2003, Clinical therapeutics.
[24] R. Mattson,et al. Topiramate, carbamazepine and valproate monotherapy: double‐blind comparison in newly diagnosed epilepsy , 2003, Acta neurologica Scandinavica.
[25] S. Gorman,et al. Characterization Of Gabapentin Overdose Using A Poison Center Case Series , 2003, Journal of toxicology. Clinical toxicology.
[26] M. Curran,et al. Gabapentin , 2003, CNS drugs.
[27] T. Tomson,et al. Risk of Extremity Fractures in Adult Outpatients with Epilepsy , 2002, Epilepsia.
[28] A. Marson,et al. Lamotrigine add-on for drug-resistant partial epilepsy. , 2016, The Cochrane database of systematic reviews.
[29] M. Morrell,et al. The Expert Consensus Guideline Series Treatment of Epilepsy , 2001, Epilepsy & Behavior.
[30] S. Schachter,et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures , 2001, Neurology.
[31] M. Kalis,et al. Oxcarbazepine, an antiepileptic agent. , 2001, Clinical therapeutics.
[32] H. Meinardi,et al. Tiagabine: Efficacy and Safety in Adjunctive Treatment of Partial Seizures , 2001, Epilepsia.
[33] P. Penovich,et al. Rapid initiation of gabapentin , 2001, Neurology.
[34] H. Shill,et al. Valproic acid toxicity mimicking multiple system atrophy , 2000, Neurology.
[35] C. Elger,et al. Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy , 2000, Epilepsia.
[36] C. Gross,et al. Factors associated with antiepileptic drug use among elderly nursing home residents. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[37] M. Brodie,et al. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy , 1999, Epilepsy Research.
[38] J. Hanlon,et al. Association of race and other potential risk factors with nonvertebral fractures in community-dwelling elderly women. , 1999, American journal of epidemiology.
[39] M. Park,et al. Lamotrigine Monotherapy in Newly Diagnosed Untreated Epilepsy: A Double‐Blind Comparison with Phenytoin , 1999, Epilepsia.
[40] M. Iivanainen,et al. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability. , 1998, Journal of intellectual disability research : JIDR.
[41] D. Chadwick,et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures , 1998, Neurology.
[42] J. Sackellares,et al. An active-control trial of lamotrigine monotherapy for partial seizures , 1998, Neurology.
[43] I. Leppik,et al. Antiepileptic Drug Use in Nursing Home Residents: Effect of Age, Gender, and Comedication on Patterns of Use , 1998, Epilepsia.
[44] S. Noachtar,et al. Gabapentin and carbamazepine affect eye movements and posture control differently: A placebo-controlled investigation of acute CNS side effects in healthy volunteers , 1998, Epilepsy Research.
[45] J. Bruni. Outcome Evaluation of Gabapentin as Add-on Therapy for Partial Seizures , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[46] J. Bruni. ECONOMIC EVALUATION OF EPILEPSY MANAGEMENT . 1996. Edited by Ch Pachlatko and RG Beran. Published by John Libbey & Company Limited. 112 pages. $C48.00 approx. , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[47] H. Diener,et al. Side effects from increased doses of carbamazepine on neuropsychological and posturographic parameters of humans , 1997, European Neuropsychopharmacology.
[48] S. Kochen,et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy 1 This study was carried out on behalf of the International Adult Oxcarbazepine/Phenytoin Trial Group (see Appendix A). 1 , 1997, Epilepsy Research.
[49] P. Wolf,et al. Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. , 1997, Archives of neurology.
[50] B. Steinhoff,et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy 1 This work was carried out on behalf of the International Oxcarbazepine/Valproate Trial Group (see Appendix A). 1 , 1997, Epilepsy Research.
[51] A. Marson,et al. The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability , 1997, BMJ.
[52] E. Ben-Menachem,et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy , 1996, Epilepsy Research.
[53] G. Pledger,et al. Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy , 1996, Epilepsia.
[54] E. Ben-Menachem,et al. Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures , 1996, Epilepsia.
[55] G. Pledger,et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages , 1996, Neurology.
[56] G Lantos,et al. Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. , 1994, Archives of neurology.
[57] W T Blume,et al. Ataxia in Institutionalized Patients with Epilepsy , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[58] I. Leppik,et al. Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. , 1994, Archives of family medicine.
[59] R. Mattson,et al. Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo‐Controlled, Double‐Blind, Cross‐Over Trial , 1994, Epilepsia.
[60] F. Matsuo,et al. Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures , 1993, Neurology.
[61] R W Baloh,et al. Disequilibrium of unknown cause in older people , 1993, Annals of neurology.
[62] N. Raz,et al. Age-related regional differences in cerebellar vermis observed in vivo. , 1992, Archives of neurology.
[63] A. Ylinen,et al. Double‐Blind Study of Gabapentin in the Treatment of Partial Seizures , 1991, Epilepsia.
[64] G. Ordog,et al. Phenytoin toxicity: a review of 94 cases. , 1989, Veterinary and human toxicology.
[65] Y. Løyning,et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy , 1989, Epilepsy Research.
[66] S. Torp,et al. Atrophy of the cerebellar vermis in ageing A morphometric and histologic study , 1986, Journal of the Neurological Sciences.
[67] E. Beghi,et al. Adverse Reactions to Antiepileptic Drugs: A Multicenter Survey of Clinical Practice , 1986 .
[68] J. Cramer,et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. , 1985, The New England journal of medicine.
[69] A. Patat,et al. Effect on postural sway of various benzodiazepine tranquillizers. , 1985, British journal of clinical pharmacology.
[70] F. Bermejo,et al. Truncal ataxia in chronic anticonvulsant treatment Association with drug-induced folate deficiency , 1982, Journal of the Neurological Sciences.
[71] F. Mcdowell,et al. Neurological sequelae following Dilantin® overdose in a patient and in experimental animals , 1965, Neurology.